《美國股市》標普500差10點擺脫熊市 工業股推動道指高收701點
美國5月就業數據強於預期,加上美國參眾議院通過債務上限法案,美聯儲下次會議估計不會加息,標普500指數周五(2日)升61.35點或1.45%,收報4,282.37點,距離2022年10月12日創下的熊市收市低位 3,577.03點接近反彈20%,僅相差約10點即可擺脫熊市。
道指高收701.19點或2.12%,報33,762.76點;納指升139.78點或1.07%,報13,240.77點。
工業股3M(MMM.US)及建築設備股Caterpillar(CAT.US)今日支撐大市,分別收升8.8%及8.4%,均創下3年最佳單日升幅。SPDR工業行業ETF(XLI.US)升2.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.